Endocrinology · Acibadem International Hospital, İstanbul Prof. Esra Nur Ademoğlu Dilekçi, MD
✓ Medically verified profileProf. Esra Nur Ademoğlu Dilekçi, MD
Prof. Esra Nur Ademoğlu Dilekçi, MD is an endocrinology specialist in the Endocrinology & Metabolism unit at Acibadem International Hospital in İstanbul. She treats thyroid diseases, including Hashimoto's disease, thyroid nodules and thyroid cancer, as well as type 1 and type 2 diabetes, prediabetes, insulin resistance and obesity. She consults in Turkish and English.
Accepting international patientsAbout Prof. Esra Nur Ademoğlu Dilekçi, MD
Prof. Esra Nur Ademoğlu Dilekçi, MD is an endocrinology specialist in the Endocrinology & Metabolism unit at Acibadem International Hospital in İstanbul. Her practice covers diabetes, prediabetes, obesity, insulin resistance and thyroid disorders, with a subspecialty focus on thyroid diseases and their treatment. She has more than 27 years in medicine and consults with patients in Turkish and English.
Dr. Dilekçi graduated from Gazi University Faculty of Medicine in 1999. She completed her internal medicine training at Ankara Numune Training and Research Hospital in 2004 and her training in endocrinology and metabolic diseases at Ankara Training and Research Hospital in 2012. She then worked at Bitlis Devlet Hospital from 2012 to 2015 and at Bolu Abant İzzet Baysal University Faculty of Medicine from 2015 to 2021. From 2021 to 2023 she practiced at Medicana Health Group-Kadıköy Hospital, and in 2023 she joined Acıbadem Healthcare Services. She is a member of the European Society of Endocrinology (ESE), the Turkish Endocrinology and Metabolic Diseases Association and the Turkey Obesity Research Association.
Clinical focus
A central part of Dr. Dilekçi’s work is thyroid disease treatment. She evaluates and manages Hashimoto’s disease, thyroid nodules and thyroid cancer, and her published research includes work on subacute thyroiditis, autoimmune thyroiditis and the attainment of recommended TSH levels in patients with differentiated thyroid cancer. Care for thyroid conditions is planned according to the individual findings, and treatment decisions are discussed with the patient after the relevant results have been reviewed.
Dr. Dilekçi also treats metabolic conditions, including type 1 diabetes, type 2 diabetes, prediabetes and insulin resistance, as well as obesity. Her research has addressed topics such as glycemic control in type 2 diabetes, predictors of diabetic retinopathy, gestational diabetes in women with obesity, polycystic ovary syndrome and acromegaly. In her clinical practice, she reviews the patient’s history, laboratory results and previous treatments before outlining possible approaches.
How Dr. Dilekçi works with international patients
Dr. Dilekçi consults in Turkish and English, and interpreters can be arranged for patients who speak other languages. Before a visit, the international patient team coordinates the collection of prior reports and imaging, such as ultrasound reports, laboratory and pathology results, operative notes and discharge summaries, and arranges appointments and the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the options. Video consultations are available for international patients who wish to discuss their thyroid or metabolic concerns before traveling or as part of follow-up.
What Dr. Dilekçi treats and performs
Each item opens the condition or treatment page with the care pathway for international patients.
Areas of practiceThyroid diseases and treatment
Conditions treated
Procedures performed
Education, career and memberships
Education & training
Education
- 2012Ankara Training and Research Hospital Endocrinology and Metabolic Diseases
- 2004Ankara Numune Training and Research Hospital Internal Medicine
- 1999Gazi University Faculty of Medicine
Career
Professional Experience
- 2023Acıbadem Healthcare Services
- 2021–2023Medicana Health Group-Kadıköy Hospital
- 2015–2021Bolu Abant İzzet Baysal University Faculty of Medicine
- 2012–2015Bitlis Devlet Hospital ( mecburi hizmet)
Memberships
Professional Memberships
- European Society of Endocrinology (ESE)
- Turkish Endocrinology and Metabolic Diseases Association
- Turkey Obesity Research Association
Selected publications
Selected Publications
- Can the systemic immune-inflammation index be used as a novel diagnostic tool in the diagnosis of subacute thyroiditis? Biomarkers in Medicine. 2022;16(10):791-797. DOI: 10.2217/bmm-2022-0095. Keskin Ç , Dilekçi ENA , Üç ZA , Cengiz D, Duran C.
- Relationship of glycemic control and diabetes duration with fibromyalgia in patients with type 2 diabetes mellitus J Bionic Mem 2022; 2(3): 87-95 Dilekçi ENA, Dilekçi E , Keskin C, Cengiz D.
- Assesment of attainment of recommended TSH levels and levothyroxine compliance in differentiated thyroid cancer patients. Clin Endocrinol (Oxf) 2022 May 31.doi: 10.1111/cen.14787. Yavuz DG, Yazan CD, Hekimsoy, Z, Aydin K, Gokkaya N, Ersoy C, Akalin A, Topaloglu Ö, Aydogan BI, Dilekçi ENA, Üç ZA, Cansu GB, Ozsari L, Iyidir ÖT,
- The acromegaly registry of ten different centers in Turkey. Growth Hormone and IGF research. 2020; 53-54:101322. DOI: 10.1016/j.ghir.2020.101322. Keskin Ç, Demir Ö, Karcı AC, Berker D, Cantürk Z, Yaylalı GF, Topsakal Ş, Ersoy R, Fahri Bayram F, Ertörer ME, Bozkırlı E, Haydardedeoğlu F, Dilekçi E
- Evaluation of Platelet Functions in Patients with Hashimoto’s Thyroiditis Versus Healthy Controls: a Cross-Sectional Analysis Clinical Laboratory, 2019;65:953-958. DOI: 10.7754/Clin.Lab.2018.181009. Gorar S, Alioglu B, Dellal FD, Ademoglu E, Uc ZA, Handan Bekdemir H, Saglam B, Culha C, Aral Y.
- Choroidal vascularity index as a predictor for the development of retinopathy in diabetic patients Journal of Endocrinological Investigation https://doi.org/10.1007/s40618-023-02236-8. C, Dilekci ENA, Ucgul AY, Ucgul YK, Toprak G, Cengiz D.
- Is circulating survivin altered in acromegaly? DOI: 10.5455/medscience.2017.06.8. Ademoglu E, Dilekçi E, Candan Z, Gorar S, Niyazoglu M, Carlioglu A, Yildiz F, Baydar I, Aslan A.
- Low levels of circulating platelet factor 4 (PF4, CXCL4) in subclinically hypothyroid autoimmune thyroiditis. Journal of Endocrinological Investigation, 2016; 39(2): 185-9. DOI: 10.1007/s40618-015-0348-x. Gorar S, Ademoglu E, Carlioglu A, Alioglu B, Bekdemir H, Saglam B, Candan Z, Ucler R, Culha C, Aral Y.
- Higher levels of circulating chemerin in obese women with gestational diabetes Mellitus. Acta Endocrinologica (Bucharest), 2015; 11(1):32-7. DOI: 10.4183/aeb.2015 Ademoglu E, Berberoglu Z, Dellal FD, Ariel MK, Kose A, Candan Z, Bekdemir H, Erdamar H, Culha C, Aral Y.
- Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome Journal of Endocrinological Investigation, 2014; 37(8): 715-9. DOI: 10.1007/s40618-014-0089-2. Ademoglu E, Gorar S, Carlioglu A, Yazici H, Dellal F D, Berberoglu Z, Akdeniz D, Uysal S, Karakurt F.
Frequently Asked Questions
Which thyroid conditions does Dr. Dilekçi treat?
Does Dr. Dilekçi also treat diabetes and obesity?
Where does Dr. Dilekçi see international patients?
What languages does Dr. Dilekçi speak?
What should I send before a case review with Dr. Dilekçi?
Can I have a video consultation with Dr. Dilekçi before traveling?
What patients say about their Acibadem care
★★★★★From 2,400+ verified reviews across the Acibadem group“My endocrine consultation was handled with real skill and genuine care. Assoc. Prof. Dilekçi was honest about my options instead of pushing treatment. I would recommend this team to anyone.”
“Assoc. Prof. Dilekçi fine-tuned my treatment and my blood sugar is steady for the first time in years.”
